LLY
StocksExclusiveExclusively on Trade XYZ. Up to 10x with USDC collateral.
About LLY
Large-cap biopharma exposure driven by diabetes, obesity, and specialty-drug leadership.
LLY tracks the value of shares in Eli Lilly and Company, a global pharmaceutical firm focused on developing treatments for diabetes, obesity, oncology, and immunology, with recent growth driven by demand for GLP-1 based therapies. The stock is widely used as a large-cap biopharma benchmark tied to innovation in metabolic disease and specialty therapeutics.
Traders can access up to 10x leverage using USDC as margin collateral. This market currently operates in isolated margin mode only. Trade XYZ has enabled Growth Mode for this asset, offering reduced trading fees.
- Tracks
- NYSE:LLY
Price Chart
Market parameters
Key market data for the live LLY perpetual on Trade XYZ. Fees shown use Tier 0 defaults with no wallet-specific discounts.